Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer clinical trial (NCT01097460). Contact the study team or your healthcare provider for specific answers.

Question 2

How does MM-111 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer clinical trial (NCT01097460). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer clinical trial (NCT01097460). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic for treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer clinical trial (NCT01097460). Contact the study team or your healthcare provider for specific answers.

Question 5

What will the treatment process involve, and how long will it last?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer clinical trial (NCT01097460). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks I should be aware of before considering this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer clinical trial (NCT01097460). Contact the study team or your healthcare provider for specific answers.

What this study is about